Shares of Integer Holdings Co. (NYSE:ITGR – Get Free Report) have received a consensus rating of “Moderate Buy” from the six brokerages that are currently covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $120.50.
Several analysts have recently weighed in on ITGR shares. Bank of America upgraded Integer from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $105.00 to $135.00 in a report on Monday, April 15th. Benchmark restated a “buy” rating and set a $130.00 price target on shares of Integer in a report on Friday. CL King assumed coverage on Integer in a report on Thursday, March 14th. They issued a “buy” rating and a $137.00 target price on the stock. Finally, KeyCorp upped their target price on Integer from $123.00 to $139.00 and gave the company an “overweight” rating in a report on Tuesday, April 9th.
Check Out Our Latest Stock Report on Integer
Hedge Funds Weigh In On Integer
Integer Stock Down 1.4 %
Shares of NYSE ITGR opened at $109.58 on Friday. The company has a current ratio of 3.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.76. The company has a market cap of $3.67 billion, a price-to-earnings ratio of 37.92, a PEG ratio of 1.54 and a beta of 1.10. Integer has a 12 month low of $69.40 and a 12 month high of $123.99. The stock has a 50-day moving average price of $113.11 and a two-hundred day moving average price of $99.92.
Integer (NYSE:ITGR – Get Free Report) last released its quarterly earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.12 by $0.02. The company had revenue of $414.80 million for the quarter, compared to analysts’ expectations of $412.78 million. Integer had a return on equity of 11.25% and a net margin of 6.01%. The business’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.87 earnings per share. As a group, analysts forecast that Integer will post 5.31 earnings per share for the current fiscal year.
About Integer
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Featured Articles
- Five stocks we like better than Integer
- What Does a Stock Split Mean?
- MarketBeat Week in Review – 4/22 – 4/26
- What to Know About Investing in Penny Stocks
- 3 Stocks Leading the U.S. Agriculture Comeback
- What is Put Option Volume?
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.